Literature DB >> 25777322

Interaction between voriconazole and flucloxacillin during treatment of disseminated Scedosporium apiospermum infection.

Brendan Kennedy1, Rebecca Larcombe2, Cassandra Chaptini3, David L Gordon3.   

Abstract

Entities:  

Keywords:  S. apiospermum; metabolism; triazoles

Mesh：

Substances：

Year:  2015        PMID： 25777322     DOI： 10.1093/jac/dkv069

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

1.  Flucloxacillin Results in Suboptimal Plasma Voriconazole Concentrations.

Authors:  Eline W Muilwijk; Bart G J Dekkers; Stefanie S V Henriet; Paul E Verweij; Bregje Witjes; Astrid M L Oude Lashof; Geert H Groeneveld; Johannes van der Hoeven; Jan Willem C Alffenaar; Frans G M Russel; Frank van de Veerdonk; Roger J M Brüggemann
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

2.  Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro.

Authors:  Tore Bjerregaard Stage; Magnus Graff; Susan Wong; Louise Ladebo Rasmussen; Flemming Nielsen; Anton Pottegård; Kim Brøsen; Deanna L Kroetz; S Cyrus Khojasteh; Per Damkier
Journal:  Br J Clin Pharmacol       Date:  2018-01-10       Impact factor: 4.335

3.  Broad-spectrum azoles and flucloxacillin: a dangerous match.

Authors:  Tine Vangheluwe; Frederik Van Hoecke; Alexander Dumoulin; Dirk Vogelaers
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-09-07       Impact factor: 3.267

4.  Interaction between posaconazole and flucloxacillin in a lung transplant patient: decrease in plasma exposure of posaconazole and possible undertreatment of invasive aspergillosis: case report.

Authors:  Saartje Verfaillie; Laurent Godinas; Isabel Spriet; Robin Vos; Geert M Verleden
Journal:  BMC Pulm Med       Date:  2022-03-27       Impact factor: 3.317
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.